TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
about
Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disordersThe FTLD risk factor TMEM106B and MAP6 control dendritic trafficking of lysosomesFrontotemporal Lobar Degeneration and MicroRNAsMechanisms of granulin deficiency: lessons from cellular and animal modelsPotential roles of microglial cell progranulin in HIV-associated CNS pathologies and neurocognitive impairmentChronic Traumatic Encephalopathy in Athletes Involved with High-impact SportsLysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106BThe ALS/FTLD associated protein C9orf72 associates with SMCR8 and WDR41 to regulate the autophagy-lysosome pathway.Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional dataAlteration of the microRNA network during the progression of Alzheimer's disease.Cognitive reserve and TMEM106B genotype modulate brain damage in presymptomatic frontotemporal dementia: a GENFI study.TMEM106B expression is reduced in Alzheimer's disease brainsRNA metabolism in neurodegenerative disease.Dissecting the role of non-coding RNAs in the accumulation of amyloid and tau neuropathologies in Alzheimer's disease.Regulated intramembrane proteolysis of the frontotemporal lobar degeneration risk factor, TMEM106B, by signal peptide peptidase-like 2a (SPPL2a).The emerging roles of microRNAs in the pathogenesis of frontotemporal dementia-amyotrophic lateral sclerosis (FTD-ALS) spectrum disordersPLD3 is accumulated on neuritic plaques in Alzheimer's disease brains.Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia.The TMEM106B locus and TDP-43 pathology in older persons without FTLDFrontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.A novel Alzheimer disease locus located near the gene encoding tau protein.Frontotemporal dementia caused by CHMP2B mutation is characterised by neuronal lysosomal storage pathology.Prosaposin facilitates sortilin-independent lysosomal trafficking of progranulin.miR-132/212 deficiency impairs tau metabolism and promotes pathological aggregation in vivo.Progranulin and Its Related MicroRNAs after Status Epilepticus: Possible Mechanisms of Neuroprotection.TMEM106B, a frontotemporal lobar dementia (FTLD) modifier, associates with FTD-3-linked CHMP2B, a complex of ESCRT-III.Functional microRNAs in Alzheimer's disease and cancer: differential regulation of common mechanisms and pathways.A study of small RNAs from cerebral neocortex of pathology-verified Alzheimer's disease, dementia with lewy bodies, hippocampal sclerosis, frontotemporal lobar dementia, and non-demented human controls.TMEM106B p.T185S regulates TMEM106B protein levels: implications for frontotemporal dementia.Progranulin Levels in Plasma and Cerebrospinal Fluid in Granulin Mutation Carriers.Expression of TMEM106B, the frontotemporal lobar degeneration-associated protein, in normal and diseased human brain.Systemic dysregulation of TDP-43 binding microRNAs in amyotrophic lateral sclerosis.Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes.A platform for discovery: The University of Pennsylvania Integrated Neurodegenerative Disease Biobank.Elevated TMEM106B levels exaggerate lipofuscin accumulation and lysosomal dysfunction in aged mice with progranulin deficiencyTMEM106B protects C9ORF72 expansion carriers against frontotemporal dementia.TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions.C9ORF72 hexanucleotide repeats in behavioral and motor neuron disease: clinical heterogeneity and pathological diversity.Microarray gene and miRNA expression studies: looking for new therapeutic targets for frontotemporal lobar degeneration.Frontotemporal Lobar Degeneration: Mechanisms and Therapeutic Strategies.
P2860
Q21129476-D55525DB-0342-4E5C-A056-595C75C0C7E7Q24314869-8BA6F9D4-619A-4516-9A02-D4FA662A9D3BQ26768177-6703DB28-6254-46E1-93BB-29AF490BC479Q26824221-EAB88D89-6771-4EC5-A3CD-6AE3E25CE5D3Q27011876-52FF967D-4231-4601-9016-CEAD3EAD99EBQ28393205-2179EDDB-E175-45B8-8AB0-3A72B63CF635Q28585799-A1E2BECF-BFDD-458A-8736-6A56FA5A8F1FQ29465536-4F3EB597-F6C9-4181-AEB7-E11E48415EB1Q30000273-0269F636-A416-4E73-B21C-8DB9788C1251Q30551542-44644299-4087-4D36-B663-BF57E9804E0FQ33729886-ED6477F0-E216-49EF-8C48-B0C44CDF9A7BQ33746240-CB3AF2A3-06DC-4C41-BBBB-2A9D9A01BE2EQ33746283-4B1BAF5C-8E76-4C80-9C56-1BAA1002C8B1Q33862621-C03FA0CF-35E6-4DDD-BF6F-3C9B84EBD7D3Q33888606-BB16B7D9-F7A2-485B-8A7A-89D59AB62631Q34353055-144C2EDC-78F1-439F-B61E-E113E8A27CE7Q34631096-DBCE1E8C-A4F2-4D0C-9781-EB1352F80F6BQ34642142-D594875D-CA17-4339-AA2F-73E5C0B8B942Q35153681-3162C7D1-745B-4A74-8B9F-A5524C7A23DBQ35204586-800B42B3-743E-4BC4-B251-606BF6F5F62FQ36070145-761088B4-649C-4159-9858-15D83E230593Q36073666-15E35874-2291-47D3-9554-FEA00CA65F4AQ36078240-E0CE9E5D-4AB8-4722-9815-48BE17EFB56AQ36251998-69137BBD-A4C9-4CF8-B8F9-D0C6A8E379F1Q36293051-09A1C4E4-1CF6-4E1D-A95C-AAF2464BF2B3Q36364206-F3315E7E-EDC8-48D9-AF6A-4A453AB5DC33Q36540471-9929EB4D-2630-44B1-9C85-117785284A2AQ37122270-39181B04-586C-4229-B00A-757396FCF089Q37154601-DBFBDA70-2A06-4067-AD10-EADDC86A968FQ37293615-04104A95-C01A-4460-9354-7C67776B9C8CQ37485507-384B0AE7-E65F-461E-8DBF-B181851248C4Q37485809-DC74ED33-C553-4727-9468-D82E01B7F0DCQ37530270-AA8B5B7D-B155-46B2-A0D8-1ECC94DA74EFQ37600861-3DD09ED9-E04C-4BA3-9583-B054EA01F2B3Q37609848-9CA1285A-CA75-48D8-9B05-12FAF69731AAQ37621660-C39ECF87-2AA1-443E-BD30-E7029E45E0F9Q37730909-4BBDF6AD-85EB-4C80-8581-1A1910A41632Q38206207-F0B34A24-E1FF-425D-9354-AB8A4BBA59FAQ38246624-49DD33C3-8AE7-4343-835F-409CB534861EQ38625515-7D7177B8-BF69-4448-A5C7-E0CF7C426E14
P2860
TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@ast
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@en
type
label
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@ast
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@en
prefLabel
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@ast
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@en
P2093
P2860
P1476
TMEM106B, the risk gene for fr ...... affects progranulin pathways.
@en
P2093
Alice S Chen-Plotkin
Emily Bill
Johanna I Busch
Laura Volpicelli-Daley
Linda K Kwong
Michael D Gallagher
Sebastian Akle
Travis L Unger
Virginia M-Y Lee
Vivianna Van Deerlin
P2860
P304
11213-11227
P356
10.1523/JNEUROSCI.0521-12.2012
P407
P577
2012-08-01T00:00:00Z